JPML Consolidates Generic Aredia Claims in New York Federal Court

WASHINGTON - The Judicial Panel on Multidistrict Litigation has granted a petition to consolidate claims in nine product liability cases against the manufacturers of the generic version of the osteoporosis drug Aredia. In re Pamidronate Products Liability Litigation, No. MDL 2120 (JPML).

On Dec. 2, JPML Chairman John G. Heyburn II centralized the actions in the U.S. District Court for the Eastern District of New York for coordinated or consolidated pretrial proceedings. The order relates to four actions in the U.S. District Court for the District of the District of Columbia, two actions each in the U.S. District Court for …